To include your compound in the COVID-19 Resource Center, submit it here.

MorphoSys gains on financial results, outlook

MorphoSys AG (Xetra:MOR) gained EUR 4.01 (11%) to EUR 41.72 on Wednesday after reporting 4Q15 and 2015 financial results, including revenues for the year that came in

Read the full 277 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE